From the Journals
Fluorescent Imaging Demystifies Melanoma
-
By
February 10, 2026
-
4 min
-
1
SFI enhances early detection of melanoma.
-
2
100% detection of oncogenic activity in melanoma cases.
-
3
Integrates molecular and visual assessments for better decision-making.
-
4
AUC score of 0.907 indicates solid performance.
-
5
Provides crucial biological information complementing dermoscopy.
-
A novel skin fluorescent imaging (SFI) system has shown promise for non-invasive, point-of-care molecular testing of challenging pigmented lesions, as confirmed by a study published in the Journal of the American Academy of Dermatology. This system has the potential to minimize unnecessary biopsies and enhance early detection of aggressive cancers. By integrating molecular data with traditional evaluation methods, dermatologists can better identify lesions at risk of melanoma, providing a significant advancement in melanoma care.
-
1
SFI enhances early detection of melanoma.
-
2
100% detection of oncogenic activity in melanoma cases.
-
3
Integrates molecular and visual assessments for better decision-making.
-
4
AUC score of 0.907 indicates solid performance.
-
5
Provides crucial biological information complementing dermoscopy.
Listen Tab content
